Stockscreener 앱 받기
1.58
4.24%
-0.07
시간 외 거래:
1.56
-0.02
-1.27%
Silexion Therapeutics Corp 주식(SLXN)의 최신 뉴스
Trading Recap: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Analyst Downgrade: Can Silexion Therapeutics Corp be recession proofMarket Trend Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress - TipRanks
Silexion Therapeutics Corp Prepares Investor Presentation on SIL204 - TradingView
Jobs Data: What is ALBTs P E ratio telling us2025 Sector Review & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Opening: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Profit Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Gap Down: Can Silexion Therapeutics Corp be recession proofQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Can Silexion Therapeutics Corp sustain its profitabilityMarket Sentiment Review & Safe Entry Point Identification - mfd.ru
Risk Hedge: Can Spring Valley Acquisition Corp II Equity Warrant sustain its profitability2025 Biggest Moves & Reliable Entry Point Alerts - baoquankhu1.vn
Investment Review: Can Silexion Therapeutics Corp Equity Warrant expand its profit marginsQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Silexion shares skyrocket 400% after encouraging pancreatic cancer drug results - MSN
Growth Value: What is the implied volatility of Silexion Therapeutics Corp2025 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit - manilatimes.net
Silexion Therapeutics to Participate in 7th RNAi-Based Therapeutics Summit Focused on Advancing SIL204 for Pancreatic Cancer - Quiver Quantitative
Will Silexion Therapeutics Corp benefit from geopolitical trendsSector ETF Performance & Free Double Digit Growth Tips - bollywoodhelpline.com
Retail Surge: Whats the RSI of Kirby Corporation stock2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Silexion reports breakthrough in KRAS cancer therapy - MSN
Signal Recap: What is the PEG ratio of Silexion Therapeutics Corp Equity Warrant2025 Key Lessons & Detailed Earnings Play Strategies - baoquankhu1.vn
Is Silexion Therapeutics Corp a defensive stockAnalyst Upgrade & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Silexion stock jumps after toxicology studies show no systemic toxicity - MSN
Can Silexion Therapeutics Corp Equity Warrant stock sustain free cash flow growthJuly 2025 Opening Moves & Fast Gain Swing Alerts - ulpravda.ru
Why Silexion Therapeutics Corp Equity Warrant stock attracts high net worth investorsFit and Size Notes & quick comparison of popular models - Улправда
Can Silexion Therapeutics Corp Equity Warrant stock beat market expectations this quarterRecession Risk & Fast Exit Strategy with Risk Control - Улправда
Dividend Watch: Will Silexion Therapeutics Corp stock deliver strong dividend growthPortfolio Risk Summary & Fast Moving Market Watchlists - Улправда
Is Silexion Therapeutics Corp stock a buy for dividend growthJuly 2025 Final Week & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why retail investors favor Silexion Therapeutics Corp stockQuarterly Market Review & Free High Accuracy Swing Entry Alerts - ulpravda.ru
How strong is Silexion Therapeutics Corp stock revenue growthProduct Launch & Entry Point Confirmation Signals - Улправда
Will Silexion Therapeutics Corp stock deliver strong dividend growthPortfolio Risk Summary & Fast Moving Market Watchlists - Улправда
What momentum indicators show for Silexion Therapeutics Corp Equity Warrant stockMarket Performance Recap & Free Long-Term Investment Growth Plans - ulpravda.ru
Will Silexion Therapeutics Corp Equity Warrant stock reach Wall Street targetsJuly 2025 Spike Watch & Daily Entry Point Trade Alerts - Улправда
Can Silexion Therapeutics Corp stock weather global recession2025 Price Action Summary & Short-Term High Return Strategies - Улправда
Signal Recap: What technical signals suggest for Silexion Therapeutics Corp stockWeekly Market Report & Consistent Growth Equity Picks - ulpravda.ru
Will Silexion Therapeutics Corp stock outperform Dow Jones indexTrade Entry Summary & Community Driven Trade Alerts - ulpravda.ru
Silexion Therapeutics CorpOrdinary Shares (NQ: SLXN - FinancialContent
Silexion outlines 2026 plans after transformational 2025 progress - TipRanks
Silexion Therapeutics Corp Highlights 2025 Achievements and 2026 Milestones - TradingView — Track All Markets
Silexion Therapeutics' Cancer Drug to Enter Human Trials in Early 2026 - marketscreener.com
Silexion Therapeutics Reports Promising Preclinical Results for SIL204 in KRAS-Driven Cancers and Plans Phase 2/3 Trial Initiation for 2026 - Quiver Quantitative
Silexion Therapeutics Releases CEO Letter to Shareholders - GlobeNewswire
Cash per share of Silexion Therapeutics Corp Warrant – NASDAQ:SLXNW - TradingView — Track All Markets
Merger Talk: Is Silexion Therapeutics Corp Equity Warrant stock trading at a premium valuation2025 Top Decliners & Daily Volume Surge Signals - Bộ Nội Vụ
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Risk Hedge: Will Silexion Therapeutics Corp stock deliver strong dividend growth2025 Market Overview & Safe Capital Growth Stock Tips - Bộ Nội Vụ
Can Silexion Therapeutics Corp Equity Warrant stock hit analyst price targetsJuly 2025 Retail & Free Technical Pattern Based Buy Signals - Улправда
Can Silexion Therapeutics Corp Equity Warrant stock hit record highs againJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - Улправда
Will Silexion Therapeutics Corp Equity Warrant stock pay special dividendsTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber
How Silexion Therapeutics Corp stock compares to growth peersQuarterly Performance Summary & Free Real-Time Market Sentiment Alerts - DonanımHaber
Risk Analysis: Can Silexion Therapeutics Corp Equity Warrant stock hit analyst price targetsPortfolio Risk Report & High Conviction Trade Alerts - Улправда
Treasury Yields: How strong is Silexion Therapeutics Corp stock revenue growthWeekly Trade Report & AI Based Buy and Sell Signals - DonanımHaber
Silexion Therapeutics (NASDAQ:SLXN) Upgraded at Zacks Research - Defense World
Can Silexion Therapeutics Corp stock sustain free cash flow growth2025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Gains Report: Will Silexion Therapeutics Corp Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & AI Driven Stock Price Forecasts - Улправда
Stop Loss: Can Silexion Therapeutics Corp Equity Warrant stock hit record highs again - Улправда
Silexion Therapeutics submits Phase 2/3 trial application - MSN
1.24%
0.19%
자본화:
|
볼륨(24시간):